Get the Stockscreener App
4.65
0.43%
0.02
After Hours:
4.67
0.02
+0.43%
Atai Life Sciences N V stock is traded at $4.65, with a volume of 2.71M.
It is up +0.43% in the last 24 hours and up +19.85% over the past month.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
See More
Previous Close:
$4.63
Open:
$4.67
24h Volume:
2.71M
Relative Volume:
0.47
Market Cap:
$996.67M
Revenue:
$2.59M
Net Income/Loss:
$-137.89M
P/E Ratio:
-5.7407
EPS:
-0.81
Net Cash Flow:
$-69.76M
1W Performance:
+2.88%
1M Performance:
+19.85%
6M Performance:
+214.19%
1Y Performance:
+257.69%
1-Day Range:
$4.495
$4.72
1-Week Range:
$4.4542
$4.99
52-Week Range:
$1.03
$5.34
Atai Life Sciences N V Stock (ATAI) Company Profile
Name
Atai Life Sciences N V
Sector
Industry
Phone
49 89 2153 9035
Address
PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN
Compare ATAI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATAI
Atai Life Sciences N V
|
4.65 | 992.39M | 2.59M | -137.89M | -69.76M | -0.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
393.21 | 101.15B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.14 | 61.07B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.59 | 59.35B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.83 | 46.29B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.27 | 35.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-25 | Initiated | Oppenheimer | Outperform |
| Nov-18-24 | Reiterated | H.C. Wainwright | Buy |
| Apr-03-24 | Upgrade | Maxim Group | Hold → Buy |
| Nov-01-22 | Initiated | Loop Capital | Buy |
| Nov-30-21 | Initiated | Maxim Group | Buy |
| Nov-11-21 | Initiated | ROTH Capital | Buy |
| Oct-18-21 | Initiated | H.C. Wainwright | Buy |
| Sep-01-21 | Initiated | Jefferies | Buy |
| Jul-13-21 | Initiated | Berenberg | Buy |
| Jul-13-21 | Initiated | Canaccord Genuity | Buy |
| Jul-13-21 | Initiated | Cantor Fitzgerald | Buy |
| Jul-13-21 | Initiated | Citigroup | Buy |
| Jul-13-21 | Initiated | Cowen | Outperform |
| Jul-13-21 | Initiated | Credit Suisse | Outperform |
| Jul-13-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Jul-08-21 | Initiated | Aegis Capital | Buy |
View All
Atai Life Sciences N V Stock (ATAI) Latest News
Pharma News: Can Atai Life Sciences NV continue delivering strong returnsEarnings Summary Report & AI Enhanced Trading Signals - خودرو بانک
Bull Run: Can Atai Life Sciences NV expand into new marketsJuly 2025 Movers & Weekly High Return Forecasts - خودرو بانک
H.C. Wainwright reaffirms Buy rating on atai Life Sciences stock at $15 target - Investing.com
atai Life Sciences to Participate in September Investor Conferences - Investing News Network
Is Atai Life Sciences N.V. stock a smart buy before Fed meetingJuly 2025 PreEarnings & Risk Managed Investment Strategies - baoquankhu1.vn
atai Life Sciences (ATAI) Upgraded to Buy: Here's What You Should Know - sharewise.com
Is a relief rally coming for Atai Life Sciences N.V. holdersJuly 2025 Update & Low Drawdown Trading Techniques - Newser
Statistical indicators supporting Atai Life Sciences N.V.’s strengthJuly 2025 Price Swings & AI Based Buy and Sell Signals - Newser
Tools to monitor Atai Life Sciences N.V. recovery probabilityMarket Performance Report & Weekly Breakout Opportunity Watchlist - Newser
Can a trend reversal in Atai Life Sciences N.V. lead to recoveryJuly 2025 Opening Moves & AI Optimized Trade Strategies - Newser
Does Atai Life Sciences N.V. offer margin of safetyPortfolio Risk Report & Long Hold Capital Preservation Tips - خودرو بانک
Will a bounce in Atai Life Sciences N.V. offer an exitJuly 2025 Gainers & Capital Protection Trading Alerts - Newser
Is Atai Life Sciences N.V. a defensive stockJuly 2025 Recap & Stepwise Trade Signal Implementation - خودرو بانک
What data driven models say about Atai Life Sciences N.V.’s future - Newser
Historical volatility pattern of Atai Life Sciences N.V. visualizedEarnings Miss & Consistent Profit Trading Strategies - Newser
Can Atai Life Sciences N.V. hit a new high this monthShare Buyback & Free Verified High Yield Trade Plans - Newser
What institutional flow reveals about Atai Life Sciences N.V.Oil Prices & Growth Focused Stock Reports - Newser
Volatility clustering patterns for Atai Life Sciences N.V.Trade Ideas & Fast Moving Market Watchlists - Newser
Movement Recap: What are Atai Life Sciences N.V.’s recent SEC filings showingMarket Sentiment Summary & Risk Controlled Daily Trade Plans - خودرو بانک
Published on: 2025-09-04 08:51:35 - Newser
How moving averages guide Atai Life Sciences N.V. tradingGlobal Markets & Detailed Earnings Play Alerts - Newser
How hedge fund analytics apply to Atai Life Sciences N.V. stock2025 Price Targets & Advanced Swing Trade Entry Alerts - Newser
Using R and stats models for Atai Life Sciences N.V. forecasting2025 Buyback Activity & Daily Growth Stock Tips - Newser
Combining price and volume data for Atai Life Sciences N.V.Weekly Gains Summary & Short-Term Swing Trade Alerts - Newser
Does Atai Life Sciences N.V. qualify in momentum factor screeningRate Cut & Weekly Chart Analysis and Trade Guides - Newser
Applying big data sentiment scoring on Atai Life Sciences N.V.Market Performance Summary & Real-Time Stock Entry Alerts - Newser
What are the analyst revisions for Atai Life Sciences N.V.Is OSTX stock a good investment in YEARQuarterly Profit Summary & Free Verified High Yield Trade Plans - خودرو بانک
Halozyme Therapeutics and atai Life Sciences N.V. Lead Medical Stocks with 53.4% and 245.1% Year-to-Date Returns Respectively. - AInvest
Are Medical Stocks Lagging Halozyme Therapeutics (HALO) This Year? - Yahoo Finance
Will Atai Life Sciences N.V. see short term momentumJuly 2025 Weekly Recap & Capital Efficiency Focused Strategies - Newser
Real time alert setup for Atai Life Sciences N.V. performanceWeekly Trade Recap & Fast Entry Momentum Trade Alerts - Newser
How to build a dashboard for Atai Life Sciences N.V. stockGap Down & Free High Accuracy Swing Entry Alerts - Newser
Will Atai Life Sciences N.V. stock go up soonEarnings Overview Summary & Weekly Top Gainers Trade List - Newser
US Market Recap: Is Atai Life Sciences N.V. undervalued by DCF analysisWeekly Profit Report & High Accuracy Trade Signal Alerts - خودرو بانک
Smart tools for monitoring Atai Life Sciences N.V.’s price actionEarnings Summary Report & High Yield Equity Trading Tips - Newser
Tools to assess Atai Life Sciences N.V.’s risk profileMarket Sentiment Report & Free Daily Entry Point Trade Alerts - Newser
What are Atai Life Sciences N.V.’s recent SEC filings showingWeekly Trade Recap & Proven Capital Preservation Methods - خودرو بانک
What machine learning models say about Atai Life Sciences N.V.2025 Institutional Moves & Daily Chart Pattern Signals - Newser
Atai Life Sciences N.V. (ATAI)’s BPL-003 Achieves Robust Phase 2b Success in Treatment-Resistant Depression - Yahoo Finance
Is Atai Life Sciences N.V. part of any ETF2025 Market Overview & Risk Controlled Swing Alerts - خودرو بانک
Has Atai Life Sciences N.V. found a price floor2025 Investor Takeaways & Weekly Chart Analysis and Guides - Newser
Volume spikes in Atai Life Sciences N.V. stock – what they meanQuarterly Earnings Report & Weekly Watchlist for Hot Stocks - Newser
Atai Life Sciences N V Stock (ATAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.33%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):